Effectiveness, safety, and patient satisfaction of carboxytherapy as an adjunctive treatment for periorbital hyperpigmentation.

CO2 therapy DECs carboxytherapy dark eye circles eye dark circles infraorbital darkening periorbital darkening periorbital hyperpigmentation trail

Journal

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
ISSN: 1600-0846
Titre abrégé: Skin Res Technol
Pays: England
ID NLM: 9504453

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 22 10 2023
accepted: 19 02 2024
medline: 14 3 2024
pubmed: 14 3 2024
entrez: 14 3 2024
Statut: ppublish

Résumé

Dark under-eye circles or periorbital hyperpigmentation constitute a prevalent and challenging cosmetic problem with diverse etiologies and types. While modifying exacerbating habits can provide partial relief for the pigmentary and vascular factors associated with this condition, and despite the abundance of available treatment options, there is currently a lack of gold-standard evidence-based treatments proposed for curing this disorder. This study aimed to assess the safety and effectiveness of carboxytherapy in treating periorbital hyperpigmentation. In this 4-week single-arm clinical trial, 20 eligible Iranian patients with symmetric periorbital hyperpigmentation received weekly intradermal carboxytherapy. The treatment involved administering 10-20 mL of CO2 at a rate of 20 mL/min and a temperature of 15°C for a duration ranging from a few seconds to 1 min. Follow-up assessments were conducted 1 month after the final session. The primary outcome was defined as the changes in ΔE or the variations in pigmentation observed between the orbital and extra-orbital skin before and after the trial. The patients reported satisfaction with the statistically significant reduction in hyperpigmentation achieved through carboxytherapy in the lateral (p = 0.002), middle (p = 0.001), and medial (p = 0.001) regions of the periorbital area. The total response rate of the patients was estimated at 20%. Patient satisfaction exceeded ΔE changes, with no significant linear relationship (p = 0.084). Carboxytherapy can be proposed as an effective and safe treatment for periorbital hyperpigmentation.

Identifiants

pubmed: 38483051
doi: 10.1111/srt.13651
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13651

Informations de copyright

© 2024 The Authors. Skin Research and Technology published by John Wiley & Sons Ltd.

Références

Nilforoushzadeh MA, Heidari-Kharaji M, Fakhim T, et al. Treatment of periorbital hyperpigmentation using sublative fractional radiofrequency (SFR). Skin Res Technol. 2023;29(9):e13467.
Gendler EC. Treatment of periorbital hyperpigmentation. Aesthet Surg J. 2005;25(6):618-624.
Coricciati L, Gabellone M, Donne PD, Pennati BM, Zingoni T. The 675-nm wavelength for treating facial melasma. Skin Res Technol. 2023;29(8):e13434.
Alter I, Fusco I, Madeddu F, Zingoni T. Clinical application of 675 nm laser therapy for dorsal hand skin hyperpigmentation. Skin Res Technol. 2023;29(10):e13484.
Masuda Y, Takahashi M, Satou A, et al. Dermatological study on dark eye circles and their treatment with newly developed cosmetics. SCCJ. 2004;38(3):202-210.
Goldman A, Goldust M, Wollina U. Periorbital hyperpigmentation-Dark circles under the eyes; treatment suggestions and combining procedures. Cosmetics. 2021;8(2):26.
Ohshima H, Mizukoshi K, Oyobikawa M, et al. Effects of vitamin C on dark circles of the lower eyelids: quantitative evaluation using image analysis and echogram. Skin Res Technol. 2009;15(2):214-217.
Sánchez JL, Vázquez M. A hydroquinone solution in the treatment of melasma. Int J Dermatol. 1982;21(1):55-59.
Ranjan R, Sarkar R, Garg VK, Gupta T. A comparative study of two modalities, 4% hydroquinone versus 30% salicylic acid in periorbital hyperpigmentation and assessment of quality of life before and after treatment. Indian J Dermatol. 2016;61(4):413.
Garcia A, Fulton JE Jr. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg. 1996;22(5):443-447.
Vavouli C, Katsambas A, Gregoriou S, et al. Chemical peeling with trichloroacetic acid and lactic acid for infraorbital dark circles. J Cosmet Dermatol. 2013;12(3):204-209.
Alster TS, Bellew SG. Improvement of dermatochalasis and periorbital rhytides with a high-energy pulsed CO2 laser: a retrospective study. Dermatol Surg. 2004;30(4 Pt 1):483-487;discussion 7.
Montolío-Marzo S, Montolío-Marzo E, Martínez-Gil C, Rodríguez-Iranzo G, Arias-García E, Pérez-López M. Treatment of periorbital hyperpigmentation using light devices. Archivos de la Sociedad Española de Oftalmología (English Edition). 2023.
Vanaman Wilson MJ, Jones IT, Bolton J, Larsen L, Wu DC, Goldman MP. Prospective studies of the efficacy and safety of the picosecond 755, 1,064, and 532 nm lasers for the treatment of infraorbital dark circles. Lasers Surg Med. 2018;50(1):45-50.
Del Duca E, Zingoni T, Bennardo L, et al. Long-term follow-up for Q-switched Nd:YAG treatment of Nevus of Ota: are high number of treatments really required? A case report. Photobiomodul Photomed Laser Surg. 2021;39(2):137-140.
Momosawa A, Kurita M, Ozaki M, et al. Combined therapy using Q-switched ruby laser and bleaching treatment with tretinoin and hydroquinone for periorbital skin hyperpigmentation in Asians. Plast Reconstr Surg. 2008;121(1):282-288.
Michelle L, Pouldar Foulad D, Ekelem C, Saedi N, Mesinkovska NA. Treatments of periorbital hyperpigmentation: a systematic review. Dermatol Surg. 2021;47(1):70-74.
Shue S, Kurlander DE, Guyuron B. Fat injection: a systematic review of injection volumes by facial subunit. Aesthetic Plast Surg. 2018;42:1261-1270.
Bosniak S, Sadick NS, Cantisano-Zilkha M, Glavas IP, Roy D. The hyaluronic acid push technique for the nasojugal groove. Dermatol Surg. 2008;34(1):127-131.
Wollina U. Improvement of tear trough by monophasic hyaluronic acid and calcium hydroxylapatite. J Clin Aesthet Dermatol. 2014;7(10):38.
Mehryan P, Zartab H, Rajabi A, Pazhoohi N, Firooz A. Assessment of efficacy of platelet-rich plasma (PRP) on infraorbital dark circles and crow's feet wrinkles. J Cosmet Dermatol. 2014;13(1):72-78.
Epstein JS. Management of infraorbital dark circles. A significant cosmetic concern. Arch Facial Plast Surg. 1999;1(4):303-307.
Paolo F, Nefer F, Paola P, Nicolò S. Periorbital area rejuvenation using carbon dioxide therapy. J Cosmet Dermatol. 2012;11(3):223-228.
Hartmann BR, Bassenge E, Hartmann M. Effects of serial percutaneous application of carbon dioxide in intermittent claudication: results of a controlled trial. Angiology. 1997;48(11):957-963.
Hartmann BR, Bassenge E, Pittler M. Effect of carbon dioxide-enriched water and fresh water on the cutaneous microcirculation and oxygen tension in the skin of the foot. Angiology. 1997;48(4):337-343.
Curri S, Bombardelli E. Local lipodystrophy and districtual microcirculation. Cosmetics and Toiletries. 1994;109(9):51-65.
Brandi C, D'Aniello C, Grimaldi L, et al. Carbon dioxide therapy in the treatment of localized adiposities: clinical study and histopathological correlations. Aesthetic Plast Surg. 2001;25(3):170-174.
Freitag FM, Cestari TF. What causes dark circles under the eyes? J Cosmet Dermatol. 2007;6(3):211-215.
Ranu H, Thng S, Goh BK, Burger A, Goh CL. Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification. Dermatol Surg. 2011;37(9):1297-1303.
Roh MR, Chung KY. Infraorbital dark circles: definition, causes, and treatment options. Dermatol Surg. 2009;35(8):1163-1171.
Sarkar R. Idiopathic cutaneous hyperchromia at the orbital region or periorbital hyperpigmentation. J Cutan Aesthet Surg. 2012;5(3):183-184.
Schnizer W, Erdl R, Schöps P, Seichert N. The effects of external CO2 application on human skin microcirculation investigated by laser Doppler flowmetry. Int J Microcirc Clin Exp. 1985;4(4):343-350.
Ferreira JCT, Haddad A, Tavares SAN. Increase in collagen turnover induced by intradermal injection of carbon dioxide in rats. J Drugs Dermatol. 2008;7(3):201.
Ito T, Moore JI, Koss MC. Topical application of CO2 increases skin blood flow. J Invest Dermatol. 1989;93(2):259-262.
Nofal E, Elkot R, Nofal A, Eldesoky F, Shehata S, Sami M. Evaluation of carboxytherapy and platelet-rich plasma in treatment of periorbital hyperpigmentation: A comparative clinical trial. J Cosmet Dermatol. 2018;17(6):1000-1007.
Ahmed NA, Mohammed SS, Fatani MI. Treatment of periorbital dark circles: Comparative study of carboxy therapy vs chemical peeling vs mesotherapy. J Cosmet Dermatol. 2019;18(1):169-175.
Assaf HA, Ahmed D, Abdelhamed A. Efficacy and safety of carboxytherapy versus combined microneedling with topical glutathione in the treatment of patients with periorbital hyperpigmentation: an evaluator-blind, split-face, controlled pilot clinical trial. Indian J Dermatol. 2022;67(5):504-511.
Asilian A, Amiri A, Mokhtari F, Faghihi G, Iraji F, Mozafarpoor S. Platelet-rich plasma versus carboxytherapy for the treatment of periocular hyperpigmentation; which approach is superior? Dermatol Ther. 2021;34(4):e14980.

Auteurs

Farnoosh Seirafianpour (F)

Razi Drug Research Center, Iran University of Medical Sciences, Tehran, Iran.

Najmolsadat Atefi (N)

Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Nazila Ghoreishi Amin (NG)

Department of Radiology, University of Southern California (USC), Los Angeles, California, USA.

Mohammad Reza Namazi (MR)

Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences (SUMS), Shahid Faghihi Hospital, Shiraz, Iran.

Elham Behrangi (E)

Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Aboozar Shafiei (A)

Department of Dermatology, School of Medicine, Shiraz University of Medical Sciences (SUMS), Shahid Faghihi Hospital, Shiraz, Iran.

Mohammadreza Ghassemi (M)

Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Samaneh Mozafarpoor (S)

Skin Diseases and Leishmaniasis Research Center, Department of Dermatology, Isfahan University of medical Sciences, Isfahan, Iran.

Azadeh Goodarzi (A)

Department of Dermatology, Rasool Akram Medical Complex Clinical Research Development Center (RCRDC), School of Medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran.

Classifications MeSH